Overview
Terence Friedlander is a Hematologist Oncology specialist and a Hematologist in Berkeley, California. Dr. Friedlander is rated as an Experienced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Urothelial Cancer, Bladder Cancer, and Prostatectomy.
His clinical research consists of co-authoring 82 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
Accepted plan types not found. Please verify directly with the provider.
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
3100 San Pablo Ave, Berkeley, CA 94702
1001 Potrero Ave, San Francisco, CA 94110
2330 Post St, San Francisco, CA 94115
400 Parnassus Ave, San Francisco, CA 94143
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
7 Clinical Trials
University Of California San Francisco
Alain Algazi is a Hematologist Oncology specialist and a Hematologist in San Francisco, California. Dr. Algazi is rated as an Elite provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Melanoma, Head and Neck Squamous Cell Carcinoma (HNSCC), Polymorphous Low Grade Adenocarcinoma, and Glioma.
Stanford Health Care
Saad Khan is an Oncologist and a Hematologist in Stanford, California. Dr. Khan is rated as a Distinguished provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Olfactory Neuroblastoma, Teratocarcinosarcoma, Anaplastic Thyroid Cancer, and Thyroid Cancer.
Regents Of The University Of California
Hyunseok Kang is a Hematologist Oncology specialist and an Oncologist in San Francisco, California. Dr. Kang is rated as a Distinguished provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Adenoid Cystic Carcinoma, Salivary Gland Tumors, Nasopharyngeal Carcinoma, Thyroid Cancer, and Gastrostomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Bladder CancerDr. Friedlander isElite. Learn about Bladder Cancer.
- Familial Prostate CancerDr. Friedlander isElite. Learn about Familial Prostate Cancer.
- Prostate CancerDr. Friedlander isElite. Learn about Prostate Cancer.
- Urothelial CancerDr. Friedlander isElite. Learn about Urothelial Cancer.
- Distinguished
- Adult Soft Tissue SarcomaDr. Friedlander isDistinguished. Learn about Adult Soft Tissue Sarcoma.
- Chromophobe Renal Cell CarcinomaDr. Friedlander isDistinguished. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Friedlander isDistinguished. Learn about Clear Cell Sarcoma.
- Muscle Invasive Bladder CancerDr. Friedlander isDistinguished. Learn about Muscle Invasive Bladder Cancer.
- Non-Muscle Invasive Bladder CancerDr. Friedlander isDistinguished. Learn about Non-Muscle Invasive Bladder Cancer.
- WT1-Related Wilms Tumor SyndromesDr. Friedlander isDistinguished. Learn about WT1-Related Wilms Tumor Syndromes.
- Advanced
- ChoriocarcinomaDr. Friedlander isAdvanced. Learn about Choriocarcinoma.
- Familial Wilms Tumor 2Dr. Friedlander isAdvanced. Learn about Familial Wilms Tumor 2.
- Metastatic Brain TumorDr. Friedlander isAdvanced. Learn about Metastatic Brain Tumor.
- Nasopharyngeal CarcinomaDr. Friedlander isAdvanced. Learn about Nasopharyngeal Carcinoma.
- Posterior Fossa TumorDr. Friedlander isAdvanced. Learn about Posterior Fossa Tumor.
- Primitive Neuroectodermal Tumor (PNET)Dr. Friedlander isAdvanced. Learn about Primitive Neuroectodermal Tumor (PNET).
- Experienced
- ALK-Positive Non-Small Cell Lung CancerDr. Friedlander isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Anal CancerDr. Friedlander isExperienced. Learn about Anal Cancer.
- Cholangiocarcinoma (Bile Duct Cancer)Dr. Friedlander isExperienced. Learn about Cholangiocarcinoma (Bile Duct Cancer).
- Colorectal CancerDr. Friedlander isExperienced. Learn about Colorectal Cancer.
- EGFR Positive Lung CancerDr. Friedlander isExperienced. Learn about EGFR Positive Lung Cancer.
- Epithelial-Myoepithelial CarcinomaDr. Friedlander isExperienced. Learn about Epithelial-Myoepithelial Carcinoma.